Global Angina Market Size, Status and Forecast 2020-2026

May 2020 | 93 pages | ID: G44D66F2587BEN
QYResearch

Abstracts

This report focuses on the global Angina status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Angina development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Amgen
• Taxus Cardium Pharmaceuticals
• LegoChem Biosciences
• Lee’s Pharmaceutical
• Milestone Pharmaceuticals
• Juventas Therapeutics
• ViroMed
• Kuhnil Pharmaceutical

Market segment by Type, the product can be split into

• Beta Blockers
• Calcium Antagonists
• Anticoagulants
• Antiplatelet
• Nitrates
• ACE inhibitors
• Ranolazine

Market segment by Application, split into

• Clinics
• Hospitals
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Angina status, future forecast, growth opportunity, key market and key players.
• To present the Angina development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Angina are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Angina Revenue
1.4 Market Analysis by Type
  1.4.1 Global Angina Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Beta Blockers
  1.4.3 Calcium Antagonists
  1.4.4 Anticoagulants
  1.4.5 Antiplatelet
  1.4.6 Nitrates
  1.4.7 ACE inhibitors
  1.4.8 Ranolazine
1.5 Market by Application
  1.5.1 Global Angina Market Share by Application: 2020 VS 2026
  1.5.2 Clinics
  1.5.3 Hospitals
  1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Angina Market Perspective (2015-2026)
2.2 Angina Growth Trends by Regions
  2.2.1 Angina Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Angina Historic Market Share by Regions (2015-2020)
  2.2.3 Angina Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Angina Market Growth Strategy
  2.3.6 Primary Interviews with Key Angina Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Angina Players by Market Size
  3.1.1 Global Top Angina Players by Revenue (2015-2020)
  3.1.2 Global Angina Revenue Market Share by Players (2015-2020)
  3.1.3 Global Angina Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Angina Market Concentration Ratio
  3.2.1 Global Angina Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Angina Revenue in 2019
3.3 Angina Key Players Head office and Area Served
3.4 Key Players Angina Product Solution and Service
3.5 Date of Enter into Angina Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Angina Historic Market Size by Type (2015-2020)
4.2 Global Angina Forecasted Market Size by Type (2021-2026)

5 ANGINA BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Angina Market Size by Application (2015-2020)
5.2 Global Angina Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Angina Market Size (2015-2020)
6.2 Angina Key Players in North America (2019-2020)
6.3 North America Angina Market Size by Type (2015-2020)
6.4 North America Angina Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Angina Market Size (2015-2020)
7.2 Angina Key Players in Europe (2019-2020)
7.3 Europe Angina Market Size by Type (2015-2020)
7.4 Europe Angina Market Size by Application (2015-2020)

8 CHINA

8.1 China Angina Market Size (2015-2020)
8.2 Angina Key Players in China (2019-2020)
8.3 China Angina Market Size by Type (2015-2020)
8.4 China Angina Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Angina Market Size (2015-2020)
9.2 Angina Key Players in Japan (2019-2020)
9.3 Japan Angina Market Size by Type (2015-2020)
9.4 Japan Angina Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Angina Market Size (2015-2020)
10.2 Angina Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Angina Market Size by Type (2015-2020)
10.4 Southeast Asia Angina Market Size by Application (2015-2020)

11 INDIA

11.1 India Angina Market Size (2015-2020)
11.2 Angina Key Players in India (2019-2020)
11.3 India Angina Market Size by Type (2015-2020)
11.4 India Angina Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Angina Market Size (2015-2020)
12.2 Angina Key Players in Central & South America (2019-2020)
12.3 Central & South America Angina Market Size by Type (2015-2020)
12.4 Central & South America Angina Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Amgen
  13.1.1 Amgen Company Details
  13.1.2 Amgen Business Overview and Its Total Revenue
  13.1.3 Amgen Angina Introduction
  13.1.4 Amgen Revenue in Angina Business (2015-2020))
  13.1.5 Amgen Recent Development
13.2 Taxus Cardium Pharmaceuticals
  13.2.1 Taxus Cardium Pharmaceuticals Company Details
  13.2.2 Taxus Cardium Pharmaceuticals Business Overview and Its Total Revenue
  13.2.3 Taxus Cardium Pharmaceuticals Angina Introduction
  13.2.4 Taxus Cardium Pharmaceuticals Revenue in Angina Business (2015-2020)
  13.2.5 Taxus Cardium Pharmaceuticals Recent Development
13.3 LegoChem Biosciences
  13.3.1 LegoChem Biosciences Company Details
  13.3.2 LegoChem Biosciences Business Overview and Its Total Revenue
  13.3.3 LegoChem Biosciences Angina Introduction
  13.3.4 LegoChem Biosciences Revenue in Angina Business (2015-2020)
  13.3.5 LegoChem Biosciences Recent Development
13.4 Lee’s Pharmaceutical
  13.4.1 Lee’s Pharmaceutical Company Details
  13.4.2 Lee’s Pharmaceutical Business Overview and Its Total Revenue
  13.4.3 Lee’s Pharmaceutical Angina Introduction
  13.4.4 Lee’s Pharmaceutical Revenue in Angina Business (2015-2020)
  13.4.5 Lee’s Pharmaceutical Recent Development
13.5 Milestone Pharmaceuticals
  13.5.1 Milestone Pharmaceuticals Company Details
  13.5.2 Milestone Pharmaceuticals Business Overview and Its Total Revenue
  13.5.3 Milestone Pharmaceuticals Angina Introduction
  13.5.4 Milestone Pharmaceuticals Revenue in Angina Business (2015-2020)
  13.5.5 Milestone Pharmaceuticals Recent Development
13.6 Juventas Therapeutics
  13.6.1 Juventas Therapeutics Company Details
  13.6.2 Juventas Therapeutics Business Overview and Its Total Revenue
  13.6.3 Juventas Therapeutics Angina Introduction
  13.6.4 Juventas Therapeutics Revenue in Angina Business (2015-2020)
  13.6.5 Juventas Therapeutics Recent Development
13.7 ViroMed
  13.7.1 ViroMed Company Details
  13.7.2 ViroMed Business Overview and Its Total Revenue
  13.7.3 ViroMed Angina Introduction
  13.7.4 ViroMed Revenue in Angina Business (2015-2020)
  13.7.5 ViroMed Recent Development
13.8 Kuhnil Pharmaceutical
  13.8.1 Kuhnil Pharmaceutical Company Details
  13.8.2 Kuhnil Pharmaceutical Business Overview and Its Total Revenue
  13.8.3 Kuhnil Pharmaceutical Angina Introduction
  13.8.4 Kuhnil Pharmaceutical Revenue in Angina Business (2015-2020)
  13.8.5 Kuhnil Pharmaceutical Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Angina Key Market Segments
Table 2. Key Players Covered: Ranking by Angina Revenue
Table 3. Ranking of Global Top Angina Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Angina Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Beta Blockers
Table 6. Key Players of Calcium Antagonists
Table 7. Key Players of Anticoagulants
Table 8. Key Players of Antiplatelet
Table 9. Key Players of Nitrates
Table 10. Key Players of ACE inhibitors
Table 11. Key Players of Ranolazine
Table 12. Global Angina Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Angina Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Angina Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Angina Market Share by Regions (2015-2020)
Table 16. Global Angina Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Angina Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Angina Market Growth Strategy
Table 22. Main Points Interviewed from Key Angina Players
Table 23. Global Angina Revenue by Players (2015-2020) (Million US$)
Table 24. Global Angina Market Share by Players (2015-2020)
Table 25. Global Top Angina Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Angina as of 2019)
Table 26. Global Angina by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Angina Product Solution and Service
Table 29. Date of Enter into Angina Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Angina Market Size by Type (2015-2020) (Million US$)
Table 32. Global Angina Market Size Share by Type (2015-2020)
Table 33. Global Angina Revenue Market Share by Type (2021-2026)
Table 34. Global Angina Market Size Share by Application (2015-2020)
Table 35. Global Angina Market Size by Application (2015-2020) (Million US$)
Table 36. Global Angina Market Size Share by Application (2021-2026)
Table 37. North America Key Players Angina Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Angina Market Share (2019-2020)
Table 39. North America Angina Market Size by Type (2015-2020) (Million US$)
Table 40. North America Angina Market Share by Type (2015-2020)
Table 41. North America Angina Market Size by Application (2015-2020) (Million US$)
Table 42. North America Angina Market Share by Application (2015-2020)
Table 43. Europe Key Players Angina Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Angina Market Share (2019-2020)
Table 45. Europe Angina Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Angina Market Share by Type (2015-2020)
Table 47. Europe Angina Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Angina Market Share by Application (2015-2020)
Table 49. China Key Players Angina Revenue (2019-2020) (Million US$)
Table 50. China Key Players Angina Market Share (2019-2020)
Table 51. China Angina Market Size by Type (2015-2020) (Million US$)
Table 52. China Angina Market Share by Type (2015-2020)
Table 53. China Angina Market Size by Application (2015-2020) (Million US$)
Table 54. China Angina Market Share by Application (2015-2020)
Table 55. Japan Key Players Angina Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Angina Market Share (2019-2020)
Table 57. Japan Angina Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Angina Market Share by Type (2015-2020)
Table 59. Japan Angina Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Angina Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Angina Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Angina Market Share (2019-2020)
Table 63. Southeast Asia Angina Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Angina Market Share by Type (2015-2020)
Table 65. Southeast Asia Angina Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Angina Market Share by Application (2015-2020)
Table 67. India Key Players Angina Revenue (2019-2020) (Million US$)
Table 68. India Key Players Angina Market Share (2019-2020)
Table 69. India Angina Market Size by Type (2015-2020) (Million US$)
Table 70. India Angina Market Share by Type (2015-2020)
Table 71. India Angina Market Size by Application (2015-2020) (Million US$)
Table 72. India Angina Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Angina Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Angina Market Share (2019-2020)
Table 75. Central & South America Angina Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Angina Market Share by Type (2015-2020)
Table 77. Central & South America Angina Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Angina Market Share by Application (2015-2020)
Table 79. Amgen Company Details
Table 80. Amgen Business Overview
Table 81. Amgen Product
Table 82. Amgen Revenue in Angina Business (2015-2020) (Million US$)
Table 83. Amgen Recent Development
Table 84. Taxus Cardium Pharmaceuticals Company Details
Table 85. Taxus Cardium Pharmaceuticals Business Overview
Table 86. Taxus Cardium Pharmaceuticals Product
Table 87. Taxus Cardium Pharmaceuticals Revenue in Angina Business (2015-2020) (Million US$)
Table 88. Taxus Cardium Pharmaceuticals Recent Development
Table 89. LegoChem Biosciences Company Details
Table 90. LegoChem Biosciences Business Overview
Table 91. LegoChem Biosciences Product
Table 92. LegoChem Biosciences Revenue in Angina Business (2015-2020) (Million US$)
Table 93. LegoChem Biosciences Recent Development
Table 94. Lee’s Pharmaceutical Company Details
Table 95. Lee’s Pharmaceutical Business Overview
Table 96. Lee’s Pharmaceutical Product
Table 97. Lee’s Pharmaceutical Revenue in Angina Business (2015-2020) (Million US$)
Table 98. Lee’s Pharmaceutical Recent Development
Table 99. Milestone Pharmaceuticals Company Details
Table 100. Milestone Pharmaceuticals Business Overview
Table 101. Milestone Pharmaceuticals Product
Table 102. Milestone Pharmaceuticals Revenue in Angina Business (2015-2020) (Million US$)
Table 103. Milestone Pharmaceuticals Recent Development
Table 104. Juventas Therapeutics Company Details
Table 105. Juventas Therapeutics Business Overview
Table 106. Juventas Therapeutics Product
Table 107. Juventas Therapeutics Revenue in Angina Business (2015-2020) (Million US$)
Table 108. Juventas Therapeutics Recent Development
Table 109. ViroMed Company Details
Table 110. ViroMed Business Overview
Table 111. ViroMed Product
Table 112. ViroMed Revenue in Angina Business (2015-2020) (Million US$)
Table 113. ViroMed Recent Development
Table 114. Kuhnil Pharmaceutical Business Overview
Table 115. Kuhnil Pharmaceutical Product
Table 116. Kuhnil Pharmaceutical Company Details
Table 117. Kuhnil Pharmaceutical Revenue in Angina Business (2015-2020) (Million US$)
Table 118. Kuhnil Pharmaceutical Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Angina Market Share by Type: 2020 VS 2026
Figure 2. Beta Blockers Features
Figure 3. Calcium Antagonists Features
Figure 4. Anticoagulants Features
Figure 5. Antiplatelet Features
Figure 6. Nitrates Features
Figure 7. ACE inhibitors Features
Figure 8. Ranolazine Features
Figure 9. Global Angina Market Share by Application: 2020 VS 2026
Figure 10. Clinics Case Studies
Figure 11. Hospitals Case Studies
Figure 12. Other Case Studies
Figure 13. Angina Report Years Considered
Figure 14. Global Angina Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global Angina Market Share by Regions: 2020 VS 2026
Figure 16. Global Angina Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Angina Market Share by Players in 2019
Figure 19. Global Top Angina Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Angina as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Angina Revenue in 2019
Figure 21. North America Angina Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe Angina Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China Angina Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan Angina Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Southeast Asia Angina Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. India Angina Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Central & South America Angina Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Amgen Revenue Growth Rate in Angina Business (2015-2020)
Figure 30. Taxus Cardium Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Taxus Cardium Pharmaceuticals Revenue Growth Rate in Angina Business (2015-2020)
Figure 32. LegoChem Biosciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. LegoChem Biosciences Revenue Growth Rate in Angina Business (2015-2020)
Figure 34. Lee’s Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Lee’s Pharmaceutical Revenue Growth Rate in Angina Business (2015-2020)
Figure 36. Milestone Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Milestone Pharmaceuticals Revenue Growth Rate in Angina Business (2015-2020)
Figure 38. Juventas Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Juventas Therapeutics Revenue Growth Rate in Angina Business (2015-2020)
Figure 40. ViroMed Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. ViroMed Revenue Growth Rate in Angina Business (2015-2020)
Figure 42. Kuhnil Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Kuhnil Pharmaceutical Revenue Growth Rate in Angina Business (2015-2020)
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed